Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$13.65 n/a | n/a%
05/22/15 - 03:59 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -38.84M -14.06M 29.95M -9.73M
Operating Gains/Losses -80.00K 0.00 0.00 58.67K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.94M 857.97K 133.15K 2.46M
(Increase) Decrease in Inventories 0.00 0.00 0.00 147.63K
(Increase) Decrease In Other Current Assets 167.00K 230.60K 360.76K 0.00
(Decrease) Increase In Payables 6.25M 130.00K -197.28K -2.13M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 619.11K
(Increase) Decrease In Other Working Capital 12.81M 1.86M -2.84M 127.16K
Other Non-Cash Items 9.45M 4.42M 4.90M 86.54K
Net Cash From Continuing Operations -12.42M -6.74M 33.27M -7.52M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -12.42M -6.74M 33.27M -7.52M
Sale of Property, Plant & Equipment 80.00K 0.00 2.50K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.06M -725.10K -14.90K -58.45K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -42.96M -725.10K -12.40K -58.45K
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 60.68M 32.72M 4.57M 4.46M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 0.00
Net Cash From Financing Activities 60.68M 32.72M 4.57M 4.46M
Effect of Exchange Rate Changes -1.83M -3.56M -29.42K 19.68K
Net Change in Cash & Cash Equivalents 3.47M 21.69M 37.80M -3.10M
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter